Trending Articles

  1. Gerresheimer adjusts 2025 guidance amid slower market growth Transformation program launched to boost performance and free cash flow
  2. Bristol Myers Squibb strengthens and diversifies cell therapy portfolio with acquisition of Orbital Therapeutics Bristol Myers Squibb will acquire Orbital Therapeutics in a $1.5bn deal, adding next-generation RNA-based in vivo CAR T technology to its cell therapy pipeline and expanding...
  3. AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the...
  4. AstraZeneca to expand Virginia manufacturing facility with $4.5bn investment, creating 3600 jobs AstraZeneca will develop a state-of-the-art manufacturing facility in Albemarle County, Virginia, producing a broader range of medicines, including weight management, metabolic...
  5. Owlstone Medical wins up to $49.1m award to develop at-home cancer detection tests The breath and urine tests are part of the POSEIDON programme, which aims to enable accurate, low-cost, accessible cancer screening for all Americans

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Finance The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable...

Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies

Read more
Finance LTS Lohmann Therapie-Systeme has agreed to acquire US-based CDMO Renaissance Lakewood, strengthening its position in nasal spray and sterile dosage form manufacturing and...

LTS expands CDMO footprint with acquisition of Renaissance Lakewood

Read more
Finance Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib

Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib

Read more
Manufacturing Transformation program launched to boost performance and free cash flow

Gerresheimer adjusts 2025 guidance amid slower market growth

Read more
Manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the...

AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing

Read more
Finance Bristol Myers Squibb will acquire Orbital Therapeutics in a $1.5bn deal, adding next-generation RNA-based in vivo CAR T technology to its cell therapy pipeline and expanding...

Bristol Myers Squibb strengthens and diversifies cell therapy portfolio with acquisition of Orbital Therapeutics

Read more
Manufacturing AstraZeneca will develop a state-of-the-art manufacturing facility in Albemarle County, Virginia, producing a broader range of medicines, including weight management, metabolic...

AstraZeneca to expand Virginia manufacturing facility with $4.5bn investment, creating 3600 jobs

Read more
Finance Axplora is investing more than €100m across its global network in 2025, with major projects in France, Italy and India aimed at strengthening small molecule API production...

Axplora announces €100m global investment drive to expand API and ADC manufacturing capacity

Read more
Finance The breath and urine tests are part of the POSEIDON programme, which aims to enable accurate, low-cost, accessible cancer screening for all Americans

Owlstone Medical wins up to $49.1m award to develop at-home cancer detection tests

Read more
Finance The funding will help fast-track clinical trials for treatments addressing dry age-related macular degeneration and severe acute hepatitis, supporting the company’s...

SeaBeLife raises €2 million to advance dual-target cell death therapies

Read more
Research & Development The company expands its international research footprint with a new San Diego institute, strengthening collaborations in one of the world’s leading life-science hubs and...

Daiichi Sankyo launches third global research institute in San Diego

Read more
Finance The SEK 2m deal will see the company’s silica-based NLAB Saga evaluated at production scale by a Chinese insulin manufacturer

Nanologica secures first insulin purification order in China

Read more
Manufacturing Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Read more
Finance The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027

Genmab to acquire Merus in $8bn deal to expand late-stage pipeline

Read more
Finance eXmoor Pharma and Siam Bioscience form a strategic partnership to establish leading cell and gene therapy services in Southeast Asia

New CGT centre in Bangkok to boost Southeast Asia’s biotech ecosystem

Read more
Finance The deal strengthens Pfizer’s position in the fast-growing obesity market, with additional milestone payments of up to $2.3bn tied to key clinical and regulatory achievements

Pfizer to acquire Metsera in $4.9bn deal, expanding obesity drug pipeline with next-generation incretin and amylin therapies

Read more